Zion Medical is an established scientific research company in the field of AIDS and cancer research. The company developed a new experimental drug, Gammora, which contains peptides derived from HIV that promote infected cells into self-induced death (apoptosis) and lentivirus manipulation in the case of cancer therapy.

An investigational medicinal product, Gammora is a synthetic peptide compound derived from the HIV enzyme integrase, which is responsible for inserting the virus's genetic material into the DNA of the infected cell. Gammora stimulates the integration of multiple HIV DNA fragments into the host cell's genomic DNA, to an extent that triggers the self-destruction of the infected cell.